Adaptin Bio, Inc.
APTN
$6.27
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.21M | -1.15M | -1.37M | -1.68M | -1.52M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Other Non-Cash Items | 443.80K | 345.40K | 176.70K | 320.10K | 250.00K |
| Change in Net Operating Assets | 311.30K | 204.40K | 488.40K | 583.10K | 248.10K |
| Cash from Operations | -450.20K | -596.30K | -702.90K | -772.40K | -1.02M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -78.50K | -92.40K | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 929.10K | 652.00K | 1.00M | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -31.30K | -121.20K | -417.00K | 0.00 | 0.00 |
| Cash from Financing | 819.30K | 438.40K | 583.00K | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 369.20K | -157.90K | -119.90K | -772.40K | -1.02M |